Tilray Brands (NASDAQ:TLRY – Get Free Report) and Else Nutrn (OTCMKTS:BABYF – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, analyst recommendations, institutional ownership and profitability.
Analyst Ratings
This is a summary of current ratings and recommmendations for Tilray Brands and Else Nutrn, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Tilray Brands | 1 | 6 | 1 | 0 | 2.00 |
| Else Nutrn | 0 | 0 | 0 | 0 | 0.00 |
Tilray Brands currently has a consensus price target of $13.33, indicating a potential upside of 84.80%. Given Tilray Brands’ stronger consensus rating and higher possible upside, equities research analysts plainly believe Tilray Brands is more favorable than Else Nutrn.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| Tilray Brands | -251.69% | -6.35% | -4.77% |
| Else Nutrn | -152.45% | -843.88% | -174.69% |
Institutional & Insider Ownership
9.4% of Tilray Brands shares are held by institutional investors. 0.8% of Tilray Brands shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Risk & Volatility
Tilray Brands has a beta of 1.95, meaning that its stock price is 95% more volatile than the S&P 500. Comparatively, Else Nutrn has a beta of 1.18, meaning that its stock price is 18% more volatile than the S&P 500.
Earnings & Valuation
This table compares Tilray Brands and Else Nutrn”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Tilray Brands | $821.31 million | 1.02 | -$2.19 billion | ($22.11) | -0.33 |
| Else Nutrn | $5.82 million | 0.49 | -$11.08 million | ($0.61) | -0.12 |
Else Nutrn has lower revenue, but higher earnings than Tilray Brands. Tilray Brands is trading at a lower price-to-earnings ratio than Else Nutrn, indicating that it is currently the more affordable of the two stocks.
Summary
Tilray Brands beats Else Nutrn on 10 of the 14 factors compared between the two stocks.
About Tilray Brands
Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.
About Else Nutrn
Else Nutrition Holdings Inc. focuses on the research, development, manufacturing, marketing, and sale of plant-based food and nutrition products for infants, toddlers, children's, and adults in North America, Israel, Australia, and New Zealand. It offers baby and toddler snacks; baby feeding accessories, such as feeding bottles and teats; plant-based baby and toddler nutrition formula products; kids and adult nutrition products; and complementary food products for babies, as well as toddler drink for toddlers ages 12-36 months; and follow-on formula for infants. The company provides its products through online. Else Nutrition Holdings Inc. was founded in 2012 and is headquartered in Tel Aviv, Israel.
Receive News & Ratings for Tilray Brands Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray Brands and related companies with MarketBeat.com's FREE daily email newsletter.
